Sector
PharmaceuticalsOpen
₹14.47Prev. Close
₹14.2Turnover(Lac.)
₹40.65Day's High
₹14.47Day's Low
₹13.952 Week's High
₹21.8952 Week's Low
₹6.15Book Value
₹7.5Face Value
₹1Mkt Cap (₹ Cr.)
317.97P/E
27.31EPS
0.52Divi. Yield
04 Dec 2023
12:00 AM
BookCloser
9 Sep 2023
12:00 AM
AGM
Announcement Date: 09 Sep, 2023
21 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
4 Dec 2023
12:00 AM
EGM
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 18.02 | 12.65 | 12.65 | 12.65 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 61 | 31.35 | 27.24 | 23.2 |
Net Worth | 79.02 | 44 | 39.89 | 35.85 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 59.64 | 55.61 | 55.8 | 43.77 |
yoy growth (%) | 7.24 | -0.33 | 27.46 | 4.46 |
Raw materials | -35.71 | -33.62 | -32.69 | -26.73 |
As % of sales | 59.88 | 60.44 | 58.59 | 61.06 |
Employee costs | -7.2 | -6.81 | -6.12 | -5.54 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 5.43 | 2.43 | 3.02 | 1.44 |
Depreciation | -0.88 | -1 | -0.98 | -0.92 |
Tax paid | -1.02 | -0.69 | -0.8 | -0.61 |
Working capital | 6.9 | 2.82 | 4.16 | -0.74 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 7.24 | -0.33 | 27.46 | 4.46 |
Op profit growth | 101.2 | -19.28 | 83.47 | -51.56 |
EBIT growth | 93.42 | -16.42 | 75.72 | -42.87 |
Net profit growth | 117.53 | -16.4 | 165.71 | -69.09 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 86.71 | 65.6 | 61.21 | 59.65 | 55.62 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 86.71 | 65.6 | 61.21 | 59.65 | 55.62 |
Other Operating Income | 4.91 | 3.95 | 1.38 | 0.52 | 0 |
Other Income | 0 | 0 | 0 | 0 | 1.06 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.45 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,520.1 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.15 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.6 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,639.05 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Y Ravinder Reddy
Chairman & Managing Director
Arihant Baid
Whole-time Director
T M GopalaKrishnan
Independent Director
Sadhana Bhansali
Independent Director
A S Nageswar Rao
Independent Director
A Ranga Rao Pantulu
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Gennex Laboratories Ltd
Summary
Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) was incorporated on June 25, 1985. The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007.The Company is one of the leading manufacturers and exporters of Active pharmaceutical ingredients and Intermediates. It is engaged in manufacturing and marketing of bulk drugs and intermediates. Gennex is among the leading Vertically Integrated pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal. The company thrives on the strength of its exports to various countries viz. Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and Others. The Companys factory is situated at Andhra Pradesh, India. The company has a professionally managed team at every stage of its operations.During the year 2005-2006, the company implemented GMP (Good Manufacturing Practices). In 2006-07, it installed Separate Air Handling System in final drug isolation area and also in drying and packing area. Also, it implemented the CGMP in manufacturing area as per ICH & WHO Guidelines. In 2007-2008, it diversified into the business of Biotech product. The Company acquired 51% shareholding in Deccan Remedies Limited and thus became the subsidiary of the Company in 2023.
Read More
What is the Gennex Laboratories Ltd share price today?
The Gennex Laboratories Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹13.98 today.
What is the Market Cap of Gennex Laboratories Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gennex Laboratories Ltd is ₹317.97 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Gennex Laboratories Ltd?
The PE and PB ratios of Gennex Laboratories Ltd is 27.31 and 1.89 as of 22 Jul ‘24
What is the 52 Week High and Low of Gennex Laboratories Ltd?
The 52-week high/low is the highest and lowest price at which a Gennex Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Gennex Laboratories Ltd is ₹6.15 and ₹21.89 as of 22 Jul ‘24
What is the CAGR of Gennex Laboratories Ltd?
Gennex Laboratories Ltd's CAGR for 5 Years at 32.25%, 3 Years at 10.97%, 1 Year at 114.83%, 6 Month at -21.29%, 3 Month at -12.18% and 1 Month at -9.61%.
What is the shareholding pattern of Gennex Laboratories Ltd?
The shareholding pattern of Gennex Laboratories Ltd is as follows:
Promoters - 18.42 %
Institutions - 0.00 %
Public - 81.58 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
